Sharon Cunningham News Today

A baby was flown to the hospital. Expect slow going through the area this evening. Parents in annapolis should also plan for some significant schoolbus delays. Run a race and you never know who might run alongside you. Today at the challenge, an annual race to raise money for guided dogs, three runners who happen to have the right skills were in the right place at the right time and may have saved a life. The life of senator tom tillis of north carolina. I am running down when i see a man down. ...

EY Entrepreneur of the Year finalists visit Cape Town ahead of crucial, historic general election next week

Crews at the Suffolk County park uncovered 16 drums that each held 55 gallons of chemicals believed to have been left there by Northrup Grumman decades ago.

Finalists will compete across three main categories over 10-month programme

CAMBRIDGE, Mass., April 08, 2024--Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for SH-201, the first palatable oral liquid of the related chemotherapeutic agent to treat certain forms of leukemia and other cancers. The Agency assigned a Prescription Drug User Fee Act ("PDUFA") action date of November 30, 2...

The FDA has accepted for review the new drug application for SH-201 for the treatment of patients with certain forms of leukemia and other cancers.

Here are some start-ups from all over the world that are ones to watch in 2024, including some big players in AI, health and climate-tech.

The FDA has announced that it had accepted the new drug application for SH-105 for the treatment of patients with breast and ovarian cancer.

Irish pharmaceutical company Shorla Oncology and consultancy firm Eversana have announced the U.S. launch of JYLAMVO, the first oral methotrexate solution.

Jylamvo, an FDA-approved oral solution formulation of methotrexate, is now available from Shorla Oncology and Eversana.